Breast Lesion Localization Methods Market Size - Global Industry, Share, Analysis, Trends and Forecast 2022 - 2030

The Global Breast Lesion Localization Methods Market Size accounted for USD 1.3 Billion in 2021 and is projected to achieve a market size of USD 4.1 Billion by 2030 rising at a CAGR of 13.8% from 2022 to 2030. Rising number of government and non-government repayment policies for the breast cancer diagnostics, biopsy, inspection, and other medical processes are projected to raise the acceptance of breast lesion localization methods.

Breast Lesion Localization Methods Market Report Statistics

• Global breast lesion localization methods market revenue is estimated to reach USD 4.1 Billion by 2030 with a CAGR of 13.8% from 2022 to 2030
• North America breast lesion localization methods market share accounted for over 36% shares in 2021
• According to the American Society of Clinical Oncology (ASCO), there are over 3.8 million women who have been diagnosed with breast cancer in the United States
• Asia-Pacific breast lesion localization methods market growth will register swift CAGR from 2022 to 2030
• Based on type, wire guided acquired over 40% of the overall market share in 2021
• Growing prevalence of breast cancer will fuel the global breast lesion localization methods market value
• Increasing demand for minimally invasive procedures is a popular breast lesion localization methods market trend that is fueling the industry demand

Global Breast Lesion Localization Methods Market Dynamics

Market Drivers

• Increasing incidences of breast cancer among women
• Surging awareness for cancer screening programs
• Rising preference for minimally invasive procedures
• Growing rate of aging population

Market Restraints

• Strict regulatory framework
• Risk related with breast localization methods

Market Opportunities

• Growing adoption of technologically advanced localization methods
• Increasing research on stem cell biology

Breast Lesion Localization Methods Market Report Coverage

Breast Lesion Localization Methods Market Growth Factors

Breast cancer is the most noticeable and invasive cancers, therefore, growing occurrence of it among women is anticipated to boost the market development.

As per Breast Cancer Organization, it was estimated that in 2018, around 266,120 new cases of invasive and 63,960 cases of non-invasive breast cancer would be detected. Increasing numeral of government and non-government compensation policies for breast cancer diagnostics, biopsy, and other related medical processes is expected to drive the acceptance of breast lesion localization approaches.

Breast Lesion Localization Methods Market Insights

Increasing need for improved healthcare infrastructure and facilities and growing consciousness level about breast cancer screening are also estimated to drive the market development. Such as, national breast cancer screening program in Australia named the Breast Screen Australia that delivers free mammogram test services every 2 years for women aged between fifty and seventy four. Emerging regions, for instance, China and India are also increasing consciousness about early analysis.

Breast Lesion Localization Methods Market Segmentation

The global breast lesion localization methods market is segmented based on type, and geography.

Breast Lesion Localization Methods Market By Type

• Wire Guided
• Radioisotope
  • Radio Guided Occult-Lesion Localization (ROLL)
  • Radioactive-Seed Localization (RSL)
  • Others
• Magnetic Tracer
• Others

According to our industry analysis of breast lesion localization methods, the wire localization segment gained a significant market share throughout the projected timeframe. The demand for this segment is being driven by factors such as its accuracy in minimal removal of normal tissues, abnormal tissue localization, minimal scarring, and the availability of reimbursement for breast lesion localization devices.

Breast Lesion Localization Methods Market Regional Outlook

North America

• U.S.
• Canada

Europe

• U.K.
• Germany
• France
• Spain
• Rest of Europe

Asia-Pacific

• India
• Japan
• China
• Australia
• South Korea
• Rest of Asia-Pacific

Latin America

• Brazil
• Mexico
• Rest of Latin America

The Middle East & Africa

• South Africa
• GCC Countries
• Rest of the Middle East & Africa (ME&A)

Breast Lesion Localization Methods Market Regional Analysis

North America captures the largest regional market and captured for 36.0% of the global market in 2018. The occurrence of well-established healthcare infrastructure and key producers in U.S. is anticipated to increase the regional development. Technological progressions paired with high economic growth in this region are also likely to boost the market.

Also, numerous activities by government and private firms to surge the consciousness is anticipated to spur the region’s growth. Such as, Wacoal America, Inc. planned a fund-raising activity, “Fit for the Cure”. The main objective was to contribute the treasuries to Susan G. Komen Breast Cancer Foundation and concurrently spread breast cancer consciousness in U.S.

Asia Pacific is anticipated to register the fastest CAGR of 16.3% during the forecast period due to high-unmet clinical needs, increasing disposable income level and patient awareness about early diagnosis. Also, speedily emerging healthcare infrastructure and growing need for breast conserving surgery are expected to provide potential development platform for this region. The industry is also driven by parameters, for instance, growing medical tourism in developing nations of APAC.

Breast Lesion Localization Methods Market Players

Market companies are concentrating on implementing new strategies for instance regional expansion, partnerships, mergers and acquisitions, new product launches, and distribution agreements to surge their revenue share. The major players associated with the breast lesion localization methods market are C.P. Medical, SOMATEX Medical Technologies GmbH, C.R. Bard, Argon Medical Devices, Inc., Cook Medical, Cianna Medical, and others.